---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-006892"
form_type: "8-K"
ticker: "XAIR"
cik: "0001641631"
company_name: "Beyond Air, Inc."
filed_at: "2025-02-14T23:59:59+00:00"
generated_at: "2026-05-26T21:24:37.004326+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Beyond Air Q3 FY2025 revenue $1.1M (+34% QoQ); cash burn $7.6M; CE Mark for LungFit PH in Europe

## Summary
- Revenue $1.1M for Dec 31, 2024 quarter, up 34% from $0.8M in prior quarter and up from $0.4M YoY.
- Cash, cash equivalents and marketable securities $10.9M; debt $11.8M; cash burn $7.6M in quarter.
- Received CE Mark for LungFit PH in Europe; market authorization in Australia; initial shipments expected later 2025.
- Six new U.S. hospital starts for LungFit PH in Q3; CE Mark triggers $1M milestone from Getz Healthcare due in Q4 FY2025.
- NeuroNOS appointed Nobel laureate Prof. Roger D. Kornberg to Scientific Advisory Board.

## SEC filing metadata
- accession: 0001493152-25-006892
- form_type: 8-K
- ticker: XAIR
- cik: 0001641631
- company_name: Beyond Air, Inc.
- filed_at: 2025-02-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641631/000149315225006892/0001493152-25-006892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641631/000149315225006892/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-006892
- JSON: https://secwatch.observer/filing/0001493152-25-006892.json
- Plain text: https://secwatch.observer/filing/0001493152-25-006892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.